Tag Archives: Oseltamivir

Natco Gilead Tamiflu ANDA

Today Natco confirmed the first to file status in press release and will have 180 days exclusivity if Natco ANDA approved by FDA. Natco ties up with Alvogen for marketing generic version in USA. As of now, Gilead has not sued … Continue reading

Posted in Patent case | Tagged , , , | 1 Comment